Literature DB >> 19094948

Varenicline and smokers with mental illnesses.

Karen E Lasser, J Wesley Boyd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19094948     DOI： 10.1016/S0140-6736(08)61513-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Varenicline for tobacco dependence: panacea or plight?

Authors:  Jill M Williams; Michael B Steinberg; Marc L Steinberg; Kunal K Gandhi; Rajiv Ulpe; Jonathan Foulds
Journal:  Expert Opin Pharmacother       Date:  2011-06-06       Impact factor: 3.889

Review 2.  Chronic obstructive pulmonary disease: an update on diagnosis and management issues in older adults.

Authors:  Shoab A Nazir; Marcia L Erbland
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 3.  Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.

Authors:  Gillian M Keating; Katherine A Lyseng-Williamson
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.